Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d - PubMed (original) (raw)

Comparative Study

Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d

G R Nemerow et al. J Virol. 1987 May.

Abstract

The major Epstein-Barr virus (EBV) envelope glycoprotein, gp350, was purified from the B95-8 cell line and analyzed for its ability to mediate virus attachment to the isolated EBV/C3d receptor (CR2) of human B lymphocytes. Purified gp350 and EBV, but not cytomegalovirus, exhibited dose-dependent binding to purified CR2 in dot blot immunoassays. Binding was inhibited by certain monoclonal antibodies to CR2 and to gp350. Liposomes bearing incorporated gp350 bound to CR2-positive B-cell lines but not to CR2-negative lines. Liposome binding was also inhibited by the OKB7 anti-CR2 monoclonal antibody. A computer-generated comparison of the deduced gp350 amino acid sequence with that of the human C3d complement fragment revealed two regions of significant primary sequence homology, a finding which suggests that a common region on these two unrelated proteins may be involved in CR2 binding.

PubMed Disclaimer

Cited by

Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein-Barr virus entry into epithelial cells.
Yang Y, Ding T, Cong Y, Luo X, Liu C, Gong T, Zhao M, Zheng X, Li C, Zhang Y, Zhou J, Ni C, Zhang X, Ji Z, Wu T, Yang S, Zhou Q, Wu D, Gong X, Zheng Q, Li X. Yang Y, et al. Nat Microbiol. 2024 May;9(5):1256-1270. doi: 10.1038/s41564-024-01659-0. Epub 2024 Apr 22. Nat Microbiol. 2024. PMID: 38649412 Free PMC article.
E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation.
Oswald J, Constantine M, Adegbuyi A, Omorogbe E, Dellomo AJ, Ehrlich ES. Oswald J, et al. Viruses. 2023 Sep 15;15(9):1935. doi: 10.3390/v15091935. Viruses. 2023. PMID: 37766341 Free PMC article. Review.
Epstein-Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement.
Miskovic R, Cirkovic A, Miljanovic D, Jeremic I, Grk M, Basaric M, Lazarevic I, Stojanovic M, Plavsic A, Raskovic S, Banko A. Miskovic R, et al. Int J Mol Sci. 2023 Mar 24;24(7):6156. doi: 10.3390/ijms24076156. Int J Mol Sci. 2023. PMID: 37047126 Free PMC article.
Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma.
Ross AM, Leahy CI, Neylon F, Steigerova J, Flodr P, Navratilova M, Urbankova H, Vrzalikova K, Mundo L, Lazzi S, Leoncini L, Pugh M, Murray PG. Ross AM, et al. Life (Basel). 2023 Feb 14;13(2):521. doi: 10.3390/life13020521. Life (Basel). 2023. PMID: 36836878 Free PMC article. Review.
Epstein-Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments.
Shechter O, Sausen DG, Gallo ES, Dahari H, Borenstein R. Shechter O, et al. Int J Mol Sci. 2022 Nov 19;23(22):14389. doi: 10.3390/ijms232214389. Int J Mol Sci. 2022. PMID: 36430864 Free PMC article. Review.

References

1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
1. J Virol. 1986 May;58(2):709-12 - PubMed
1. J Clin Pathol. 1979 Feb;32(2):122-7 - PubMed
1. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5307-11 - PubMed
1. J Immunol. 1981 Jul;127(1):272-8 - PubMed

Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d - PubMed (original) (raw)